178 related articles for article (PubMed ID: 2074910)
1. Gastric mucosal prostaglandin E2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal disease, and in healthy subjects.
Weiler H; Weiler C; Gerok W
Neth J Med; 1990 Dec; 37(5-6):189-96. PubMed ID: 2074910
[TBL] [Abstract][Full Text] [Related]
2. Decreased prostaglandin E2 immunoactivity of gastric mucosa in portal hypertension.
Weiler H; Weiler CH; Gerok W
Neth J Med; 1991 Feb; 38(1-2):4-12. PubMed ID: 2030809
[TBL] [Abstract][Full Text] [Related]
3. Gastric mucosal PGE2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal diseases and in healthy subjects.
Weiler H; Weiler C; Gerok W
Dig Dis Sci; 1990 Dec; 35(12):1488-93. PubMed ID: 2253534
[TBL] [Abstract][Full Text] [Related]
4. Decreased gastric prostaglandin E2 synthesis in patients with gastric ulcers and in smokers.
Baumeister B; Schmidt C; Schiermeyer-Dunkhase B; Vetter H; Kipnowski J
Hepatogastroenterology; 1995; 42(6):851-5. PubMed ID: 8847034
[TBL] [Abstract][Full Text] [Related]
5. Enzyme immunoassay of gastric luminal prostaglandin E2 in duodenal ulcer disease.
Calabrò A; Orsini B; Fedi P; Falchini M; Surrenti C
Am J Gastroenterol; 1989 Jun; 84(6):629-32. PubMed ID: 2658552
[TBL] [Abstract][Full Text] [Related]
6. Healing of chronic gastric ulcer depends on gastric mucosal prostaglandin synthesis.
Mine T; Kataoka A; Fujisaki J; Sato E; Yasuda H; Inaba Y; Akimoto K; Mashima H; Ogata E
Hepatogastroenterology; 1994 Apr; 41(2):111-5. PubMed ID: 8056395
[TBL] [Abstract][Full Text] [Related]
7. Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia.
Taha AS; Boothman P; Holland P; McKinlay A; Upadhyay R; Kelly RW; Lee F; Russell RI
Am J Gastroenterol; 1990 Jan; 85(1):47-50. PubMed ID: 2296963
[TBL] [Abstract][Full Text] [Related]
8. Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma.
Wright JP; Young GO; Klaff LJ; Weers LA; Price SK; Marks IN
Gastroenterology; 1982 Feb; 82(2):263-7. PubMed ID: 7054027
[TBL] [Abstract][Full Text] [Related]
9. Patients with chronic renal failure are not at a risk of developing chronic peptic ulcers.
Andriulli A; Malfi B; Recchia S; Ponti V; Triolo G; Segoloni G
Clin Nephrol; 1985 May; 23(5):245-8. PubMed ID: 4006334
[TBL] [Abstract][Full Text] [Related]
10. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
11. [Morphologic changes of gastric mucosa in Helicobacter pylori infection in patients with peptic ulcer disease and chronic gastritis].
Raczyńska A; Jarczyk G; Jarczyk J; Jedrzjczyk W
Pol Merkur Lekarski; 1996 Sep; 1(3):165-8. PubMed ID: 9139779
[TBL] [Abstract][Full Text] [Related]
12. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer.
Aydemir SA; Tekin IO; Numanoglu G; Borazan A; Ustundag Y
Mediators Inflamm; 2004 Dec; 13(5-6):369-72. PubMed ID: 15770055
[TBL] [Abstract][Full Text] [Related]
14. [Prostaglandin and cyclic nucleotide levels in patients with peptic ulcer and chronic gastritis with secretory insufficiency].
Valenkevich LN; Zaĭchuk ASh
Ter Arkh; 1987; 59(2):29-31. PubMed ID: 3472366
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 in duodenal ulcer complications.
Goldman G; Tiomny E; Halpern Z; Kahn PJ; Hallak A; Somjen D; Wiznitzer T; Gilat T
Am Surg; 1992 Jan; 58(1):49-52. PubMed ID: 1739230
[TBL] [Abstract][Full Text] [Related]
16. The gastric mucosa in duodenal, gastric, and prepyloric ulceration.
Lawson HH
Scand J Gastroenterol Suppl; 1984; 92():156-62. PubMed ID: 6588506
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Toll-like receptor 2, 4, 6 and 9 genome DNA mutations in patients with tractable and intractable gastric mucosal diseases.
Ohara T; Morishita T; Hashimoto H; Akimoto M; Kanoh Y; Nakajima N; Suzuki H; Hibi T
Int J Mol Med; 2006 Jan; 17(1):53-8. PubMed ID: 16328011
[TBL] [Abstract][Full Text] [Related]
18. Il-2 receptor expression on gastric mucosa T lymphocytes is enhanced in duodenal ulcer patients compared with non-ulcer dyspeptic patients.
Ihan A; Tepez B; Kavcic I; Gubina M
Hepatogastroenterology; 1996; 43(12):1665-70. PubMed ID: 8975986
[TBL] [Abstract][Full Text] [Related]
19. Upper gastro-intestinal mucosal changes in patients with chronic renal failure.
Goenka MK; Kochhar R; Mehta SK; Nagi B; Malik AK; Chugh KS
J Assoc Physicians India; 1989 Sep; 37(9):564-6. PubMed ID: 2632557
[TBL] [Abstract][Full Text] [Related]
20. Gastroduodenal mucosa in peptic ulcer: endoscopic and histological assessment.
Chattopadhyay G; Basu K; Mukherjee S; Hazra BR
Trop Gastroenterol; 1997; 18(4):156-9. PubMed ID: 9612096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
